{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:37:29Z","timestamp":1787503049292,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Therapeutic drug monitoring (TDM) of immunosuppressive drugs is important for the prevention of allograft rejection in transplant patients. Several hospitals offer a microsampling service that provides patients the opportunity to sample a drop of blood from a fingerprick at home that can then be sent to the laboratory by mail. The aim of this study was to pilot an external quality control program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Fourteen laboratories from 7 countries participated (fully or partly) in 3 rounds of proficiency testing for the immunosuppressants tacrolimus, ciclosporin, everolimus, sirolimus, and mycophenolic acid. The microsampling devices included the following: Whatman 903 and DMPK-C, HemaXis, Mitra, and Capitainer-B. All assays were based on liquid chromatography with tandem mass spectrometry. In round 2, microsamples as well as liquid whole blood samples were sent, and 1 of these samples was a patient sample.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Imprecision CV% values for the tacrolimus microsamples reported by individual laboratories ranged from 13.2% to 18.2%, 11.7%\u201316.3%, and 12.2%\u201318.6% for rounds 1, 2, and 3, respectively. For liquid whole blood (round 2), the imprecision CV% values ranged from 3.9%\u20134.9%. For the other immunosuppressants, the results were similar. A great variety in analytical procedures was observed, especially the extraction method. For the patient sample, the microsample results led to different clinical decisions compared with that of the whole blood sample.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Immunosuppressant microsampling methods show great interlaboratory variation compared with whole blood methods. This variation can influence clinical decision-making. Thus, harmonization and standardization are needed. Proficiency testing should be performed regularly for laboratories that use immunosuppressant microsampling techniques in patient care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001019","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T04:00:25Z","timestamp":1660622425000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Results From a Proficiency Testing Pilot for Immunosuppressant Microsampling Assays"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4929-4834","authenticated-orcid":false,"given":"Herman","family":"Veenhof","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands;"},{"name":"Department of Association for Quality Assessment in Therapeutic Drug Monitoring and Clinical Toxicology (KKGT), Quality Assessment in Medical Laboratories (SKML), Nijmegen, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco A.","family":"Koster","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands;"},{"name":"ICON Bioanalytical Laboratory, Assen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenneke A.T.","family":"Junier","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zweipfenning","sequence":"additional","affiliation":[{"name":"Department of Association for Quality Assessment in Therapeutic Drug Monitoring and Clinical Toxicology (KKGT), Quality Assessment in Medical Laboratories (SKML), Nijmegen, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands;"},{"name":"Department of Association for Quality Assessment in Therapeutic Drug Monitoring and Clinical Toxicology (KKGT), Quality Assessment in Medical Laboratories (SKML), Nijmegen, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transpl."},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/ndt\/gfq096","article-title":"High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation","volume":"25","author":"Borra","year":"2010","journal-title":"Nephrol Dial Transpl."},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jpba.2006.11.023","article-title":"Therapeutic drug monitoring of tacrolimus with the dried blood spot method","volume":"44","author":"Hoogtanders","year":"2007","journal-title":"J Pharm Biomed Anal."},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal Chem."},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FTD.0000000000000864","article-title":"Alternative sampling devices to collect dried blood microsamples: state-of-the-art","volume":"43","author":"Delahaye","year":"2021","journal-title":"Ther Drug Monit."},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00228-015-1863-6","article-title":"Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique","volume":"71","author":"van Boekel","year":"2015","journal-title":"Eur J Clin Pharmacol."},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cca.2013.02.009","article-title":"Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS\/MS","volume":"421","author":"Sadilkova","year":"2013","journal-title":"Clinica Chim Acta"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4155\/bio-2016-0296","article-title":"Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS\/MS systems","volume":"9","author":"Koster","year":"2017","journal-title":"Bioanalysis"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.talanta.2013.04.027","article-title":"Fast LC-MS\/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery","volume":"115","author":"Koster","year":"2013","journal-title":"Talanta"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jchromb.2013.02.035","article-title":"Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry","volume":"926","author":"Koop","year":"2013","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jchromb.2011.05.016","article-title":"Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry","volume":"883-884","author":"Hinchliffe","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/bcp.13755","article-title":"Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device","volume":"84","author":"Zwart","year":"2018","journal-title":"Br J Clin Pharmacol."},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/FTD.0000000000000655","article-title":"Tacrolimus can be reliably measured with volumetric absorptive capillary microsampling throughout the dose interval in renal transplant recipients","volume":"41","author":"Vethe","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4155\/bio-2018-0312","article-title":"A volumetric absorptive microsampling LC\u2013MS\/MS method for five immunosuppressants and their hematocrit effects","volume":"11","author":"Koster","year":"2019","journal-title":"Bioanalysis"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"122521","DOI":"10.1016\/j.jchromb.2020.122521","article-title":"Volumetric absorptive microsampling for the quantification of tacrolimus in capillary blood by high performance liquid chromatography-tandem mass spectrometry","volume":"1165","author":"Tron","year":"2021","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1515\/cclm-2019-0053","article-title":"Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients","volume":"57","author":"Veenhof","year":"2019","journal-title":"Clin Chem Lab Med."},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/TP.0000000000001591","article-title":"Clinical validation of simultaneous analysis of tacrolimus, Cyclosporine A and creatinine in dried blood spots in kidney transplant patients","volume":"101","author":"Veenhof","year":"2017","journal-title":"Transplantation"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/0004563213488759","article-title":"Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots","volume":"51","author":"Hinchliffe","year":"2014","journal-title":"Ann Clin Biochem."},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/petr.12392","article-title":"Tacrolimus and sirolimus in capillary dried blood spots allows for remote monitoring","volume":"19","author":"Dickerson","year":"2015","journal-title":"Pediatr Transpl."},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/FTD.0000000000000422","article-title":"Dried blood spot sampling for tacrolimus and mycophenolic acid in children: analytical and clinical validation","volume":"39","author":"Martial","year":"2017","journal-title":"Ther Drug Monit."},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/ajt.15199","article-title":"Assessment of tacrolimus intra\u2010patient variability in stable adherent transplant recipients: establishing baseline values","volume":"19","author":"Leino","year":"2019","journal-title":"Am J Transpl."},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1515\/cclm-2019-1260","article-title":"Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring","volume":"58","author":"Veenhof","year":"2020","journal-title":"Clin Chem Lab Med."},{"key":"R25-20260519","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1373\/clinchem.2011.172080","article-title":"The need for standardization of tacrolimus assays","volume":"57","author":"Levine","year":"2011","journal-title":"Clin Chem."},{"key":"R26-20260519","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/FTD.0000000000000094","article-title":"Transplant patient classification and tacrolimus assays: more evidence of the need for assay standardization","volume":"36","author":"Agrawal","year":"2014","journal-title":"Ther Drug Monit."},{"key":"R27-20260519","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/FTD.0000000000000205","article-title":"Impact of laboratory practices on interlaboratory variability in therapeutic drug monitoring of immunosuppressive drugs","volume":"37","author":"Christians","year":"2015","journal-title":"Ther Drug Monit."},{"key":"R28-20260519","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1373\/clinchem.2013.209114","article-title":"Standardization of LC-MS for therapeutic drug monitoring of tacrolimus","volume":"59","author":"Annesley","year":"2013","journal-title":"Clin Chem."},{"key":"R29-20260519","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/FTD.0000000000000269","article-title":"Assuring the proper analytical performance of measurement procedures for immunosuppressive drug concentrations in clinical practice: recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee","volume":"38","author":"Seger","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R30-20260519","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40262-014-0197-3","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Robijns","year":"2014","journal-title":"Clin Pharmacokinet."},{"key":"R31-20260519","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Wilhelm","year":"2014","journal-title":"Clin Pharmacokinet."},{"key":"R32-20260519","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R33-20260519","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4155\/bio.14.298","article-title":"What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?","volume":"7","author":"Koster","year":"2015","journal-title":"Bioanalysis"},{"key":"R34-20260519","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/FTD.0b013e318192304c","article-title":"Robust, high-throughput LC-MS\/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood","volume":"31","author":"Koster","year":"2009","journal-title":"Ther Drug Monit."},{"key":"R35-20260519","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/ac503931g","article-title":"New microfluidic-based sampling procedure for overcoming the hematocrit problem associated with dried blood spot analysis","volume":"87","author":"Leuthold","year":"2015","journal-title":"Anal Chem."},{"key":"R36-20260519","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00007691-199506000-00009","article-title":"Stability of FK 506 in whole blood samples","volume":"17","author":"Freeman","year":"1995","journal-title":"Ther Drug Monit."},{"key":"R37-20260519","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2165\/00003088-199324060-00004","article-title":"Cyclosporin clinical pharmacokinetics","volume":"24","author":"Fahr","year":"1993","journal-title":"Clin Pharmacokinet."},{"key":"R38-20260519","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1093\/jac\/dku242","article-title":"Five year results of an international proficiency testing programme for measurement of antifungal drug concentrations","volume":"69","author":"Lempers","year":"2014","journal-title":"J Antimicrob Chemother."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:00:22Z","timestamp":1779224422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001019","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"2022-05-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}